Expert consensus indicates that NMN, NR, and spermidine are all natural compounds with a favorable safety profile.
Classification: Industry News
Publication:2024-03-25 09:14
Aging and its retardation are among the most pressing frontiers in contemporary life sciences. Identifying strategies to slow aging is of paramount importance for enhancing physical function, improving quality of life, and extending healthspan in older adults. Focusing on interventions targeting aging—by elucidating the fundamental processes of human aging and treating aging as a systemic decline in organ‑level functions, or by adopting a “preventive” approach to delay, prevent, or mitigate the onset and progression of age‑related diseases—holds significant practical relevance. Pharmacological interventions play an irreplaceable role in slowing aging; however, there remain considerable disagreements regarding criteria for assessing their efficacy, as well as the pathways and methods through which they exert their effects, leading to ongoing debate.
Recently, the Geriatric Medicine Branch of the Chinese Medical Association convened leading experts in the field of pharmacological interventions for aging to hold an academic symposium. The meeting comprehensively reviewed and summarized the mechanisms of action, preclinical and clinical evidence, and recent advances related to currently popular anti‑aging agents, focusing on first‑generation drugs, second‑generation drugs, stem cell therapies, and traditional Chinese medicine. Participants discussed the feasibility of conducting clinical trials and implementing these agents, as well as potential intervention strategies, ultimately formulating the “Chinese Geriatric Medicine Expert Consensus on Pharmacological Interventions for Aging (2024)” (hereinafter referred to as the “Consensus”). This document aims to facilitate the translation of anti‑aging drug research into clinical practice while contributing to the enhancement of health care and medical services for middle-aged and older adults.
Notably, NMN, NR, and spermidine have all been included. “The Chinese Geriatric Medicine Expert Consensus on Research into Pharmacological Interventions for Delaying Aging (2024)” states that the consensus indicates… NMN, NR, and spermidine All are natural products with good safety and tolerability.
NAD+ supplements: NAD+ is a coenzyme that participates in redox reactions and is converted into reduced nicotinamide adenine dinucleotide (NADH). It is involved in NAD… − The cellular metabolic processes involving redox reactions include glycolysis, the tricarboxylic acid cycle, and… ⁻ 3 ⁻ Fatty acid oxidation, among others. In mammals, within the body… NAD+ NAD+ levels decline with age, and so does the activity of sirtuins. NAD+ supplements can elevate NAD+ levels in mice and extend their healthspan. Since cells cannot directly take up NAD+, direct supplementation with NAD+ is ineffective. Researchers have leveraged the NAD+ biosynthetic pathway to increase intracellular NAD+ levels by supplementing NAD+ precursors. Studies have demonstrated that nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) exert anti‑aging effects in both invertebrate and murine models.
Both NR and NMN are natural compounds with a favorable safety profile in human studies. While they differ to some extent in bioavailability and stability, it remains unclear which is more effective. To date, NR has undergone several small‑scale clinical trials. These studies have shown that, in older men, three weeks of NR supplementation can reduce levels of inflammatory cytokines. However, dietary NR supplementation did not improve metabolic parameters in obese men with insulin resistance. Furthermore, oral NR enhances mitochondrial respiration in peripheral blood mononuclear cells and downregulates the expression of pro‑inflammatory cytokine genes in patients with heart failure; it may also help ameliorate hypertension and aortic stiffness in middle‑aged and older adults, thereby supporting cardiovascular health.
Animal model studies have shown that NMN can ameliorate age‑related diseases, including diabetes, heart failure, and Alzheimer’s disease. Six weeks of NMN supplementation enhanced aerobic capacity during exercise training in young and middle‑aged recreational runners. Research by Yoshino et al. demonstrated that 10 weeks of NMN supplementation improved muscle insulin sensitivity in overweight or obese women with prediabetes. NMN supplementation holds promise for preventing disability and alleviating fatigue in older adults. Large‑scale clinical trials are urgently needed to determine whether NR or NMN confers health benefits in humans, and given that NAD+ supplements are already available as over‑the‑counter products, elucidating their role in delaying aging is of paramount importance.
Suggestions and Recommendations: Both NR and NMN are natural compounds with a favorable safety profile and can help alleviate certain age‑related degenerative diseases.
Spermidine: Spermidine is a naturally occurring polyamine that plays a critical role in regulating gene expression, apoptosis and autophagy, as well as cell growth and proliferation; its levels in the human body decline with age. Spermidine is found in a variety of dietary sources, including grapefruit, soy products, legumes, corn, whole grains, peas, green peppers, broccoli, oranges, green tea, rice bran, and fresh green peppers. It is also present in shiitake mushrooms, wheat germ, cauliflower, broccoli, and various aged cheeses and durian. Studies have shown that increasing intake of spermidine‑rich foods can reduce overall mortality associated with cardiovascular disease and cancer. Furthermore, spermidine treatment markedly attenuated calcification in isolated rat and human arterial rings as well as in the aorta. Research indicates that six weeks of spermidine supplementation can improve B‑cell function in humans. Given that spermidine can reverse the age‑related reductions in polyamine synthesis and autophagy observed in chondrocytes during aging and in osteoarthritic cartilage, it also holds promise as a preventive agent for osteoarthritis.
Spermidine may be used to treat age‑related memory decline, and supplementation with spermidine has been shown to prevent neurodegeneration and cognitive impairment in aged animal models. Studies have indicated that, among older adults aged 60–80 years, supplementation with a spermidine‑rich plant extract (1.2 mg/day) is well tolerated and safe, with positive effects on memory (Phase III trial). Furthermore, a Phase IIb trial conducted at a German academic clinical research center, which employed a spermidine‑enriched dietary supplement (0.9 mg/day), found that long‑term spermidine supplementation did not alter memory or biomarkers in participants reporting subjective cognitive decline; the potential effects on verbal memory and inflammation will need to be confirmed in future studies using higher doses.
Suggestions and Recommendations: In animal studies, there is substantial evidence that spermidine supplementation improves health and extends lifespan, and human epidemiological data also suggest dietary spermidine confers related benefits. Current data indicate that spermidine holds therapeutic potential in cardiovascular protection, neuroregulation and neuroprotection, and the amelioration of metabolic disorders, with a favorable safety profile and good tolerability.
Article link:
Liu Youshuo, Zhan Junkun, Wang Jianye, et al. Chinese Expert Consensus on Pharmacological Interventions for Delaying Aging (2024) [J]. Chinese Journal of Geriatrics, 2024, 43(02): 148–161. DOI: 10.3760/cma.j.issn.0254-9026.2024.02.002
Leave a Message Online
Shanghai Public Security Bureau Internet Information Service Security Filing No. 31011502015262